AMPH·03209R103·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
AMPH (AMPHASTAR PHARMACEUTICALS IN) is held by 113 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($106.2M), DIMENSIONAL FUND ADVISORS LP ($39.7M), STATE STREET CORP ($31.5M). Net institutional sentiment: Mixed.
See how AMPH's score breaks down across 4 SEC sources
Showing 1-20 of 134
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer